• No se han encontrado resultados

DEPARTAMENT DE COMUNICACIÓ

In document Memòria = Memoria 2013 (página 51-56)

Sub-Goal: Strengthen health systems to support the delivery of quality health care services.

Measure FY Target Result

32.1: Percent of RECA successful claimants screened at RESEP centers.

(Outcome)

Out-Year

Target 8.8% (FY 2013) Nov 30, 2014 2008 N/A 8.5%

(Baseline) 32.2: Percent of patients screened at

RESEP clinics who file RECA claims that receive RECA benefits.

(Outcome)

Out-Year

Target 72% (FY 2013) Nov 30, 2014 2008 N/A 70%

(Baseline) 32.I.A.1: Total number of individuals

screened per year.

(Output)

2012 1,400 Nov 30, 2013

2011 1,400 Nov 30, 2012

2010 1,400 Nov 30, 2011

2009 1,800 1,373

(Target Not Met)

2008 1,700 1,270

(Target Not Met)

2007 2,225 1,689

(Target Not Met but Improved)

EfficiencyMeasure FY Target Result

32.E: Average cost of the program per individual screened. (Efficiency) 2012 $1,397 Dec 31, 2013 2011 $923 Dec 31, 2012 2010 $720 Dec 31, 2011 2009 $760 $1,249

(Target Not Met)

2008 $810 $1,195

(Target Not Met)

2007 $850 $923

(Target Not Met)

Measure Data Source Data Validation

32.1

32.2 Department of Justice (DOJ) Validated by DOJ. 32.I.A.1

32.E Annual grantee data reports Verified by project officers.

INTRODUCTION

The measures focus on identifying possible patients who may have suffered radiation poisoning and providing needed services to them for screening. The measures also focus on helping to determine if eligible patients might be eligible to seek compensation through the filing of Radiation Exposure and Compensation Act claims. The annual measure focuses on increasing the number of individuals screened each year. The data from the performance measures are used

157

to refine the actual guidance for the grantees to focus more explicitly on the activities that directly impact the ability to identify and screen affected patients. The program is also partnering with the Department of Justice to collect data in support of long-term performance measures.

The measures support HRSA’s Strategic Plan Goal I of improving access to quality health care and services through strengthening health systems to support the delivery of quality health services.

DISCUSSION OF RESULTS AND TARGETS

Goal: Improve Access to Quality Health Care and Services

Sub-Goal: Strengthen health systems to support the delivery of quality health care services. 32.1. Percent of RECA successful claimants screened at RESEP centers.

This long-term measure reflects RESEP's primary purpose to screen and educate those that might be eligible for compensation under the Radiation Exposure Compensation Act. The measure was determined by comparing the number of successful RECA claimants screened through RESEP centers (i.e., the numerator) with the total number of successful RECA claimants (i.e., the

denominator). The 3-year rolling baseline for FY 2008 is 8.5% and the long-term target is 8.8% for FY 2013.

32.2. Percent of patients screened at RESEP clinics who actually receive RECA benefits. This long-term measure reflects the program's efforts to accurately screen and refer individuals potentially eligible for RECA claims. Findings from RESEP's screenings must be confirmed outside the screening program through definitive diagnostic tests in order for an individual to receive benefits. The measure was determined by comparing the number of successful RECA claimants screened through RESEP centers as reported to the Department of Justice (i.e., the numerator) with the total number of RECA claimants screened at RESEP centers as reported to the Department of Justice (i.e., the denominator). The baseline for FY 2008 is 70% and the long- term target is 72% for FY 2013.

32.I.A.1. Total number of individuals screened per year.

This annual measure indicates the total number of individuals adversely affected by the mining, transport and processing of uranium and the testing of nuclear weapons for the Nation’s weapons arsenal screened at RESEP centers. This measure defines screening as including:

1) occupational history, 2) medical history, 3) physical examination, 4) diagnostic testing (when appropriate), and 5) access to a range of comprehensive services including outreach, education, case management, referrals for treatment, and assistance in applying for RECA compensation. The population of former uranium mine workers continues to require the services of this program. To increase the number of people screened, efforts were made to identify individuals who were potentially exposed but no longer lived in the local area. The program has shown a consistent increase in users from FY 2005 to FY 2007: 1,551 (FY 2005), 1,464 (FY 2006), and

158

1,689 (FY 2007). This number declined in FY 2008 to 1,270 individuals screened but increased in FY 2009to 1,373 (below the target of 1,800). The FY 2008 and FY 2009 results are

somewhat lower than previous years due to the rapidly aging former uranium mine worker population in which potential patients have passed away as well as the relocation of this population from the original mining sites. The FY 2012 target is 1,400 individuals screened. 32.E. Average cost of the program per individual screened.

The efficiency measure compares the total costs of the program to the program's outcome of getting individuals screened. The average cost per individual screened is based on the fiscal year dollars spent to pay for the screenings. The costs include all education and outreach efforts as well as the costs of the screening exams. In FY 2006 the program showed an average cost of $1,084, which did not meet the target of $893. In FY 2007, the program showed an average cost of $923, which did not meet the target of $850. The average cost in FY 2008 was $1,195 which did not reach its target of $850. The average cost in FY 2009 was $1,249 which did not reach its target of $760. The average costs for FY 2006 through FY 2009 can be associated with the varying number of individuals screened each year as well as increases in various costs related to testing procedures for the detection of radiogenic disease and cancer. The FY 2012 target is $1,397.

159

BLACK LUNG CLINICS

In document Memòria = Memoria 2013 (página 51-56)